Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
乐伐替尼联合帕博利珠单抗治疗既往未接受过治疗或既往接受过治疗的转移性肾细胞癌患者（研究 111/KEYNOTE-146）：一项 1b/2 期研究
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(21)00241-2
Lee, Chung-Han; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Krohn; Richards, Donald; Sweis, Randy F; Courtright, Jay; Heinrich, Daniel; Jain, Sharad; Wu, Jane; Schmidt, Emmett V; Perini, Rodolfo F; Kubiak, Peter; Okpara, Chinyere E; Smith, Alan D; Motzer, Robert J
